Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.3100
-0.0050 (-1.59%)
Jan 30, 2026, 2:31 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 136.55 million as of January 29, 2026. Its market cap has decreased by -19.39% in one year.
Market Cap
136.55M
Enterprise Value
119.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 136.55M, an increase of 321.39%. That is a compound annual growth rate of 14.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 136.55M | -6.28% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 194.43M |
| Recce Pharmaceuticals | 189.42M |
| Actinogen Medical | 153.20M |
| Starpharma Holdings | 146.97M |
| Proteomics International Laboratories | 118.87M |
| Island Pharmaceuticals | 113.00M |
| Imugene | 110.32M |
| LTR Pharma | 106.26M |